Skip to main navigation Skip to search Skip to main content

Flexible trial design in practice - stopping arms for lack-of-benefit and adding research arms mid-trial in STAMPEDE: a multi-arm multi-stage randomized controlled trial

  • Matthew R Sydes
  • , Mahesh K B Parmar
  • , Malcolm D Mason
  • , Noel W Clarke
  • , Claire Amos
  • , John Anderson
  • , Johann de Bono
  • , David P Dearnaley
  • , John Dwyer
  • , Charlene Green
  • , Gordana Jovic
  • , Alastair W S Ritchie
  • , J Martin Russell
  • , Karen Sanders
  • , George Thalmann
  • , Nicholas D James

Research output: Contribution to journalArticlepeer-review

86 Citations (Scopus)

Abstract

Systemic Therapy for Advanced or Metastatic Prostate cancer: Evaluation of Drug Efficacy (STAMPEDE) is a randomized controlled trial that follows a novel multi-arm, multi-stage (MAMS) design. We describe methodological and practical issues arising with (1) stopping recruitment to research arms following a pre-planned intermediate analysis and (2) adding a new research arm during the trial.
Original languageEnglish
Pages (from-to)168
JournalTrials
Volume13
DOIs
Publication statusPublished - 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Flexible trial design in practice - stopping arms for lack-of-benefit and adding research arms mid-trial in STAMPEDE: a multi-arm multi-stage randomized controlled trial'. Together they form a unique fingerprint.

Cite this